What is the EVAX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Evaxion Biotech A/S (EVAX) price will be around $2.78 in the next 2 weeks. This means it will decrease by -7.980132450331129 from the last closing price. This prediction may vary from other time period filters for EVAX stock.

What can be the highest Possible price of EVAX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, EVAX can achieve the highest price of $2.94 which is -2.4989694131030413 lower than last closing price. This prediction may vary from other time period filters for EVAX stock.

What can be the lowest Possible price of EVAX stock in next 2 weeks?

As per the forecast and algorithmic analysis, EVAX stock price can be as low as $2.62 which is -13.410556687727555 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for EVAX stock.

Will EVAX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that EVAX stock will lose-7.980132450331129 in the next 2 weeks. This prediction may vary from other time period filters for EVAX stock.

What is EVAX stock last closing price?

Last closing price of EVAX stock was $3.02.

What is EVAX stock price prediction?

EVAX stock price prediction means predicting the future closing prices of EVAX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of EVAX stock in a certain time period.

How we predict EVAX stock future prices?

If you are searching for EVAX stock forecast, analysis or price prediction, then you might be wondering what Evaxion Biotech A/S (EVAX) will do in the future. Our EVAX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This EVAX price prediction will likely answer most of your questions.

How frequent we update EVAX stock predictions?

We are updating the forecasts for the EVAX stock on daily basis.

Is using ML forecasting for EVAX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for EVAX stock same for all the time periods?

No, the prediction for EVAX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Evaxion Biotech A/S Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$3.02-7.08%Since 2 Weeks

Predicted Price$2.78-7.98%For 2 Weeks

Upper Predicted Price$2.94-2.5%For 2 Weeks

Lower Predicted Price$2.62-13.41%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of EVAX will decline by -7.98% over the next 2 Weeks and hit $2.78 by Tuesday, August 4, 2026. In that time frame, EVAX's share price is expected to range between $2.62 and $2.94.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 4, 2026	2.62	2.78	2.94
Aug 3, 2026	2.68	2.84	2.99
Jul 31, 2026	2.64	2.81	2.97
Jul 30, 2026	2.66	2.83	2.98
Jul 29, 2026	2.69	2.84	2.99
Jul 28, 2026	2.70	2.86	3.03
Jul 27, 2026	2.76	2.92	3.08
Jul 24, 2026	2.74	2.90	3.06
Jul 23, 2026	2.76	2.91	3.07
Jul 22, 2026	2.76	2.93	3.08

EVAX shares rose +2.25% in Wednesday, July 22, 2026's trading session, rising from a previous close of $3.02 to move at $3.09. The stock demonstrated notable intraday movement (see EVAX's key stats for a full breakdown), fluctuating between $3.09 and $3.17, a +2.66% trading range. While recent weeks have seen some volatility, EVAX has managed to secure a -4.99% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 8.8K shares changing hands, 145 fewer than the previous session. This amounted to $27.17K in total market activity.

Will EVAX Continue Its Downward Trend?

According to analyst ratings and projections for EVAX, Evaxion Biotech A/S shares are anticipated to decrease by -4.87%, potentially reaching $2.94 per share by August 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for EVAX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the EVAX stock forecast, now is not the best time to buy EVAX stock because its current trading price is +11.12% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on EVAX covering social and institutional perspectives.

EVAX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into EVAX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.91% to 50.57%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.87%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.32%, maintains a neutral outlook for the long term. Insights into EVAX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Evaxion Biotech A/S Short-Term Forecasts

EVAX Forecast For Next 5 Days

Our algorithm anticipates Evaxion Biotech A/S (EVAX) stock could hit $2.74 by Jul 29, 2026. This represents a -11.14% fall from today's price, following a -9.65% change over the past five days.

EVAX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Evaxion Biotech A/S (EVAX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.53, which would mean a -18.07% decrease from the current price of $3.09. Projections for this period range from a high of $3.05 to a low of $1.91.

EVAX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Evaxion Biotech A/S's price over the next three months point to a drop. EVAX stock is expected to peak at $4.62 on Oct 09, 2026 after potentially dipping to $1.08 on Aug 10, 2026. On average, EVAX is likely to trade around $2.89 in the coming 90 days.

Evaxion Biotech A/S Stock Forecast 2025

Based on our predictive models, Evaxion Biotech A/S (EVAX) is expected to trade between $1.08 and $5.01 throughout 2026. This would result in an average price of $2.86, potentially offering investors a -7.38% return from current levels.

Evaxion Biotech A/S Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Evaxion Biotech A/S (EVAX) is positioned to show a strong performance in July 2026. The price is predicted to move between $1.94 and $4.25, settling at an average of $3.22. This could translate to a +4.28% gain.

August 2026

Based on current market signals, Evaxion Biotech A/S is projected to trend august 2026. We forecast a trading range from $1.08 to $3.46, with a likely average price of $2.31. Investors could expect a potential return of -25.19%.

September 2026

Our predictive algorithms indicate Evaxion Biotech A/S stock may see a shift in September 2026. The expected range spans $1.59–$4.52, with an average target of $2.91. This represents a cautious outlook and a possible loss of -5.76%.

October 2026

Analyzing established trends, Evaxion Biotech A/S looks set to move in October 2026. Projections place the stock between $1.94 and $4.62, averaging around $3.29. This suggests a +6.54% gain from current levels.

November 2026

Market indicators suggest Evaxion Biotech A/S could experience notable changes during November 2026. Prices could fluctuate within $1.61 to $5.01, with a midpoint forecast of $3.02. The stock might deliver a -2.20% loss.

December 2026

Forecasting for December 2026, models estimate that Evaxion Biotech A/S may undergo key fluctuations. If trends hold, the stock might trade between $1.13 and $3.79, averaging $2.62. This signals a cautious trajectory with potential returns around -15.15%.

January 2027

According to our latest forecast models, Evaxion Biotech A/S (EVAX) is positioned to show a strong performance in January 2027. The price is predicted to move between $1.20 and $3.92, settling at an average of $2.77. This could translate to a -10.30% loss.

February 2027

Based on current market signals, Evaxion Biotech A/S is projected to trend february 2027. We forecast a trading range from $0.87 to $3.24, with a likely average price of $2.34. Investors could expect a potential return of -24.22%.

March 2027

Our predictive algorithms indicate Evaxion Biotech A/S stock may see a shift in March 2027. The expected range spans $0.00–$3.06, with an average target of $1.75. This represents a cautious outlook and a possible loss of -43.33%.

April 2027

Analyzing established trends, Evaxion Biotech A/S looks set to move in April 2027. Projections place the stock between $0.06 and $2.71, averaging around $2.13. This suggests a -31.02% loss from current levels.

May 2027

Market indicators suggest Evaxion Biotech A/S could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $2.53, with a midpoint forecast of $2.31. The stock might deliver a -25.19% loss.

June 2027

Forecasting for June 2027, models estimate that Evaxion Biotech A/S may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.68, averaging $1.48. This signals a cautious trajectory with potential returns around -52.07%.

July 2027

According to our latest forecast models, Evaxion Biotech A/S (EVAX) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $1.37, settling at an average of $2.14. This could translate to a -30.70% loss.

EVAX's history of dividends and stock splits also plays a role in long-term investor confidence.